The Medical Science Liaison (MSL) will represent our Client and its lead product candidate that is intended to treat solid tumors as a single agent and in combination with other therapies, and is currently being evaluated in a Phase 2 clinical trial.
The MSL will deliver clinical and scientific data, and technical/practical education, to thought leaders, primary investigators and other stakeholders within the medical oncology community. The MSL is responsible for developing, coordinating and assuring implementation of our clients corporate, scientific, and clinical strategies to these thought leaders within academic, clinical, and healthcare organizations. The MSL will build long-term peer-to-peer relationships and establish rapport with these thought leaders through highly scientific product and disease-related discussions. These scientific exchanges will support and/or expand current single agent and/or combination immuno-therapy therapeutic concepts, as well as ensure the safe and effective utilization of our Client’s product(s).
Additionally, the MSL will support our Client’s research initiatives, clinical trial enrollment and participate in and contribute to projects and initiatives that increase the value and productivity of the Medical Affairs team.